Cited by 8Tissue Engineering and Regenerative MedicineCardiac Valve Diseases and TreatmentsMesenchymal stem cell research

Future prospects in the tissue engineering of heart valves: a focus on the role of stem cells

Open access
Albert, Benjamin J, Butcher, Jonathan T·2023·Expert Opinion on Biological Therapy

Abstract

INTRODUCTION: Heart valve disease is a growing burden on the healthcare system. Current solutions are insufficient for young patients and do not offer relief from reintervention. Tissue engineered heart valves (TEHVs) offer a solution that grows and responds to the native environment in a similar way to a healthy valve. Stem cells hold potential to populate these valves as a malleable source that can adapt to environmental cues. AREAS COVERED: This review covers current methods of recapitulating features of native heart valves with tissue engineering through use of stem cell populations with in situ and in vitro methods. EXPERT OPINION: In the field of TEHVs, we see a variety of approaches in cell source, biomaterial, and maturation methods. Choosing appropriate cell populations may be very patient specific; consistency and predictability will be key to long-term success. In situ methods are closer to translation but struggle with consistent cellularization. In vitro culture requires specialized methods but may recapitulate native valve cell populations with higher fidelity. Understanding how cell populations react to valve conditions and immune response is vital for success. Detrimental valve pathologies have proven to be difficult to avoid in early translation attempts.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/14712598.2023.2214313

Cites

127 of 127 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Matrix materials for heart valve design demand superior and anisotropic mechanical properties, presenting significant challenge for PLCL alone.

    “the matrix materials used for heart valve design demand superior and anisotropic mechanical properties, presenting a significant challenge for PLCL alone [168, 169].”

    From Application of PLCL as a biodegradable polymer in biomedical engineering (2026) · cites this paper as [169]

    The paper’s “Anatomy and function of heart valves” section says valve leaflets have anisotropic behavior that is important to their function. “Recapitulating VIC/VEC function in TEHVs” says engineered valves need to closely match healthy-valve mechanics. Neither passage establishes that PLCL alone cannot meet those requirements, so the PLCL-specific challenge is unsupported. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Heart valves must continuously open and close while enduring constant hemodynamic stresses, and direction of valve movement and pressure distribution vary with anatomical location.

    “Heart valves must continuously open and close while enduring constant hemodynamic stresses. Moreover, the direction of valve movement and the pressure distribution vary with their anatomical location.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Albert, B. J., & Butcher, J. T.
Affiliations
Cornell University (US)
Corresponding author
Butcher, Jonathan T
Venue
Expert Opinion on Biological Therapy
Published
2023-05-16
Volume
23
Issue
6
Pages
553-564
ISSN
  • 1471-2598 (ISSN-L)
  • 1744-7682
OpenAlex
W4376225328
Cited by
8
References
127
Citations by year
2026: 4 · 2025: 2 · 2024: 1 · 2023: 1
FWCI
0.52
Type
journal article
Language
en
Open access
Locations
  • Expert Opinion on Biological Therapy (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Science Foundation (DGE-1650441)
  • National Institutes of Health (R01 HL151190)
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
Keywords
tissue-engineered heart valves, stem cells, valvular heart disease, biomaterials, immune response, translational research
MeSH terms
Biocompatible Materials, Heart Valve Prosthesis, Heart Valves, Humans, Stem Cells, Tissue Engineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review